SCHEMBL7184273

SCHEMBL7184273

CCOP(=O)(O)c1cc(-c2ccc(CBr)cc2)ccc1C=Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2D Q9UNK4 1/20 0.40
▸ GGPS1 O95749 2/20 0.38
▸ EED O75530 1/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ GLA P06280 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180293 0.88 PLA2G2D (0.40) PLA2G2DGGPS1EEDNR1I2PTPN1
SCHEMBL7184264 0.83 CYP1A1 (0.37) GGPS1PTPN1ALDH1A1KDM4EMEN1
SCHEMBL7184261 0.83 CYP1A1 (0.37) GGPS1PTPN1ALDH1A1KDM4EMEN1
SCHEMBL7596789 0.80 PTPN1 (0.47) PLA2G2DGGPS1EEDPTPN1
SCHEMBL7527451 0.76 ALDH1A1 (0.39) PTPN1ALDH1A1CYP3A4L3MBTL1LMNA
SCHEMBL7188009 0.73 ALDH1A1 (0.47) PTPN1ALDH1A1
SCHEMBL7181991 0.73 CFD (0.42) PTPN1ALDH1A1POLB
SCHEMBL7186784 0.70 ALDH1A1 (0.44) PTPN1ALDH1A1KDM4EHTT
SCHEMBL7596781 0.69 PTPN1 (0.43) PTPN1ALDH1A1KDM4EMEN1GLA
SCHEMBL7596785 0.69 PTPN1 (0.43) PTPN1ALDH1A1KDM4EMEN1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268494-A1 SULFUR SUBSTITUTED ARYLDIFLUOROMETHYLPHOSPHONIC ACIDS AS PTP-1B INHIBITORS Merck Frosst Canada & Co. (CA) 2003-01-02 — — EP disclosed
US-6498151-B2 PROTEIN TYROSINE PHOSPHATASES INHIBITORS, ESPECIALLY AS ANTIDIABETIC AGENTS MERCK FROSST CANADA & CO. (CA) 2002-12-24 — — US disclosed
US-20020091104-A1 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors MERCK FROSST CANADA LTD. (CA) 2002-07-11 — — US disclosed
WO-2001070753-A1 SULFUR SUBSTITUTED ARYLDIFLUOROMETHYLPHOSPHONIC ACIDS AS PTP-1B INHIBITORS MERCK FROSST CANADA & CO. (CA) 2001-09-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091104-A1 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors PTPRF, PTPRS, PTPRO PLA2G2D 1720/4885GGPS1 1722/4885EED 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback